The report provides a detailed analysis essential for establishing a Roxithromycin production plant. It encompasses all critical aspects necessary for Roxithromycin production, including the cost of Roxithromycin production, Roxithromycin plant cost, Roxithromycin production costs, and the overall Roxithromycin production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Roxithromycin production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Roxithromycin is a semisynthetic antibiotic, and its main applications are related to healthcare and medicine. It is widely utilized for the treatment of respiratory tract infections, such as pneumonia, acute bronchitis, and acute infection of chronic bronchitis. Moreover, it also finds its application in the treatment of genitourinary system infection due to its strong bactericidal effect on both Gram-negative bacteria and Gram-positive bacteria. Additionally, it is also employed in the treatment of soft tissue bacterial infections, including skin, muscles, ligaments, and tendons.
The market for Roxithromycin is primarily driven due to its broad antibacterial spectrum, which significantly boosts its demand in the medical industry. Moreover, its utilization as an oral drug for the treatment of various respiratory and genital tract infections further enhances its demand in the medical and pharmaceutical industries. Furthermore, the availability of raw materials (erythromycin, hydroxylamine hydrochloride, etc.), cost and pricing, compliance with medical regulations, and quality standards are some of the factors that significantly influence industrial Roxithromycin procurement globally.
Raw Material for Roxithromycin Production
According to the Roxithromycin production plant project report, the major raw materials for Roxithromycin production include Erythromycin- Hydroxylamine Hydrochloride-Triethylamine-Methanol-Methoxyethoxymethyl Chloride-Acetone.
Production Process of Roxithromycin
The extensive Roxithromycin production cost report consists of the following industrial production process:
- Production from Erythromycin: This method of production involves the use of erythromycin as a starting raw material for producing roxithromycin as a product. The process is initiated by the reaction of erythromycin with hydroxylamine hydrochloride in the presence of triethylamine and methanol to form oxime. Further, the obtained oxime is reacted with methoxyethoxymethyl chloride in the presence of acetone, which results in the formation of roxithromycin.
Roxithromycin is a semi-synthetic derivative of the macrolide antibiotic erythromycin. The molecular formula of the compound is C41H76N2O15, and its molar mass is 837.05 g/mol. Moreover, the compound exists in the form of white to off-white powder, has a bitter taste and is not soluble in water but gets easily dissolved in chloroform, ethanol, and acetone. Additionally, it is stored sealed, in a dry place, and at a temperature of 2-8°C. The melting point of the compound is 111-118°C, and its boiling point is 864.7°C. The density of the compound is 1.25 g/cm3, and its flash point is >110°(230°F).
